Dasiglucagon Shows Promise in Mitigating Hypoglycemia after bariatric surgery Dr Riya Dave19 Jan 2024 11:00 AM ISTIn a significant development for individuals grappling with postbariatric hypoglycemia after Roux-en-Y gastric bypass surgery, dasiglucagon, a stable...
Novo Nordisk, Zealand Pharma collaborate for ZEGALOGUE for injection Ruchika Sharma9 Sept 2022 11:33 AM ISTUnder the terms of the agreement, Zealand will receive an upfront payment of DKK 25 million and is eligible to receive up to DKK 45 million in...
Dasiglucagon cuts IV glucose requirement in Pediatric Patients with Congenital Hyperinsulinism: Phase 3 Trial Dr. Kamal Kant Kohli20 May 2022 7:45 PM ISTreducing the requirement for IV glucose
Dasiglucagon effectively reduces postprandial hypoglycemia after bariatric surgery Medha Baranwal26 April 2022 10:15 AM ISTDenmark: A recent study in the journal Diabetes Care showed that dasiglucagon effectively reduced postprandial hypoglycemia in Roux-en-Y gastric...
Dasiglucagon Reduces Severe Hypoglycemia in Patients with Type 1 Diabetes MD Bureau7 May 2021 10:45 AM ISTAchieving tight glycaemic control without severe hypoglycaemia still presents a complex challenge in insulin-treated diabetes. Closed-loop artificial...
Dasiglucagon effective treatment for postprandial hypoglycemia after weight loss surgery: Study Medha Baranwal19 July 2020 9:09 PM ISTDenmark: Dasiglucagon could be a new therapeutic option for the management of postprandial hypoglycemia (low blood sugar) after weight loss surgery,...
